Abselion
UK-based company which specializes in automated analytical instrumentation that simplifies at-line protein quantification
Cambridge, UKwww.abselion.com ↗
Total raised
€8.0M
€7,974,877
Funding rounds
1
Investors
6
distinct backers
Active since
2024-12
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood49
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-09 | Series A | €8.0M | BGF,BioProcess 360 Partners,Existing investors,M Ventures,R42 Group,Untitled Ventures | View deal → |